These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The use of estrogen in older women. Birge SJ Clin Geriatr Med; 2003 Aug; 19(3):617-27, viii. PubMed ID: 14567012 [TBL] [Abstract][Full Text] [Related]
7. Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? Birge SJ J Am Geriatr Soc; 1996 Jul; 44(7):865-70. PubMed ID: 8675940 [TBL] [Abstract][Full Text] [Related]
8. Prognostic features of menopausal and postmenopausal applicants for life insurance. Schiefeling M J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866 [TBL] [Abstract][Full Text] [Related]
9. [Contemporary views on use of estrogen replacement therapy in postmenopausal women. I. Hormone therapy in women with menopausal osteoporosis]. Krasomski G Ginekol Pol; 1995 Jan; 66(1):28-31. PubMed ID: 8522210 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of alternatives to hormone replacement therapy in postmenopausal healthy women. Bjarnason NH Dan Med Bull; 2005 May; 52(2):64-81. PubMed ID: 16009050 [No Abstract] [Full Text] [Related]
11. Action of estrogens in the aging brain: dementia and cognitive aging. Henderson VW Biochim Biophys Acta; 2010 Oct; 1800(10):1077-83. PubMed ID: 19913598 [TBL] [Abstract][Full Text] [Related]
12. [Effects of estrogen and selective estrogen receptor modulators on osteoporosis]. Urano T Clin Calcium; 2005 Apr; 15(4):591-5. PubMed ID: 15802770 [TBL] [Abstract][Full Text] [Related]
14. [Basic principles of hormone replacement therapy in the postmenopause]. Dören M Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374 [TBL] [Abstract][Full Text] [Related]
15. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Brinton RD Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751 [TBL] [Abstract][Full Text] [Related]
16. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women. Lee WL; Chao HT; Cheng MH; Wang PH Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794 [TBL] [Abstract][Full Text] [Related]
18. [Estrogens and selective estrogen receptor modulators in the treatment of osteoporosis]. Ribot C; Tremollieres F; Pouilles JM Ann Med Interne (Paris); 2000 Oct; 151(6):490-6. PubMed ID: 11104929 [TBL] [Abstract][Full Text] [Related]
19. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast. Pickar JH; Komm BS Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836 [TBL] [Abstract][Full Text] [Related]